The primary PRISM Repurposing dataset contains the results of pooled-cell line chemical-perturbation viability screens for 4,518 compounds screened against 578 or 562 cell lines.
The secondary PRISM Repurposing dataset contains the results of pooled-cell line chemical-perturbation viability screens for 1,448 compounds screened against 499 cell lines in a 8-step, 4-fold dilution, starting from 10μM.
According to the DepMap PRISM repurposing page:
However, when I look at the drug sensitivity function, it only mentions the primary screen.
Is there a reason the secondary screen is not included in this package?